High-dose 131I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan

被引:0
|
作者
Daiki Kayano
Hiroshi Wakabayashi
Kenichi Nakajima
Rie Kuroda
Satoru Watanabe
Anri Inaki
Ayane Toratani
Norihito Akatani
Takafumi Yamase
Yuji Kunita
Tomo Hiromasa
Aki Takata
Hiroshi Mori
Shintaro Saito
Raita Araki
Junichi Taki
Seigo Kinuya
机构
[1] Kanazawa University,Department of Nuclear Medicine, Kanazawa University Hospital and Department of Nuclear Medicine, Institute of Medical, Pharmaceutical and Health Science
[2] Kanazawa University,Department of Functional Imaging and Artificial Intelligence
[3] Kanazawa University,Department of Pediatrics, Kanazawa University Hospital and Department of Pediatrics, Institute of Medical, Pharmaceutical and Health Science
[4] Kanazawa Medical University,Department of Radiology
[5] Ishikawa Prefectural Central Hospital,Department of Pediatrics
来源
关键词
I-metaiodobenzylguanidine; Refractory neuroblastoma; Relapsed neuroblastoma; Internal radiation therapy; Radionuclide therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:397 / 406
页数:9
相关论文
共 50 条
  • [41] Megatherapy combining I131 metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma
    Miano, M
    Garaventa, A
    Pizzitola, MR
    Lo Piccolo, MS
    Dallorso, S
    Villavecchia, GP
    Bertolazzi, C
    Cabria, M
    De Bernardi, B
    BONE MARROW TRANSPLANTATION, 2001, 27 (06) : 571 - 574
  • [42] Megatherapy combining I131 metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma
    M Miano
    A Garaventa
    MR Pizzitola
    MSLo Piccolo
    S Dallorso
    GP Villavecchia
    C Bertolazzi
    M Cabria
    B De Bernardi
    Bone Marrow Transplantation, 2001, 27 : 571 - 574
  • [43] Transient sialoadenitis:: A complication of 131I-Metaiodobenzylguanidine therapy
    Modak, Shakeel
    Pandit-Taskar, Neeta
    Kushner, Brian H.
    Kramer, Kim
    Smith-Jones, Peter
    Larson, Steven
    Cheung, Nai-Kong V.
    PEDIATRIC BLOOD & CANCER, 2008, 50 (06) : 1271 - 1273
  • [44] Sequential treatment of High-risk Neuroblastoma combining I-131 MIBG high-dose and Topotecan. First experience
    Orrego, N.
    Prado-Wohlwend, S.
    Balaguer-Guill, J.
    Torres-Espallardo, I.
    Part-Lopez, M.
    Guerrero-Calatayud, C.
    Canon-Sanchez, J.
    Montesinos-Gonzalez, S.
    Bello-Arques, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S672 - S672
  • [45] Pinhole imaging of 131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma
    Roberto Accorsi
    Michael J. Morowitz
    Martin Charron
    John M. Maris
    Pediatric Radiology, 2003, 33 : 688 - 692
  • [46] I-131-mIBG therapy in high-risk neuroblastoma patients at end of induction chemotherapy
    Schmidt, M. C.
    Hero, B.
    Decarolis, B.
    Eggert, A.
    Berthold, F.
    Drzezga, A.
    Simon, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S772 - S772
  • [47] Peripheral Blood Biomarkers Associated With Toxicity and Treatment Characteristics After 131I-Metaiodobenzylguanidine Therapy in Patients With Neuroblastoma
    Campbell, Kevin
    Karski, Erin E.
    Olow, Aleksandra
    Edmondson, David A.
    Kohlgruber, Ayano C.
    Coleman, Matthew
    Haas-Kogan, Daphne A.
    Matthay, Katherine K.
    DuBois, Steven G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : 468 - 475
  • [48] Nurses' Experiences Caring for Children With Neuroblastoma Receiving 131I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive Study
    Lankin, Kelly
    LaFond, Cynthia M.
    Yost, Alyssa
    JOURNAL OF PEDIATRIC HEMATOLOGY-ONCOLOGY NURSING, 2023, 40 (02): : 82 - 90
  • [49] Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial
    Matthay, Katherine K.
    Weiss, Brian
    Villablanca, Judith G.
    Maris, John M.
    Yanik, Gregory A.
    DuBois, Steven G.
    Stubbs, James
    Groshen, Susan
    Tsao-Wei, Denice
    Hawkins, Randall
    Jackson, Hollie
    Goodarzian, Fariba
    Daldrup-Link, Heike
    Panigrahy, Ashok
    Towbin, Alexander
    Shimada, Hiroyuki
    Barrett, John
    LaFrance, Norman
    Babich, John
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (07) : 1155 - 1163
  • [50] Results of High-Dose Treosulfan-Containing Regimen in Patients With High-Risk Neuroblastoma
    Shamanskaya, T.
    Kachanov, D.
    Hachatryan, L.
    Khismatullina, R.
    Moiseenko, R.
    Teleshova, M.
    Skorobogatova, E.
    Druy, A.
    Zemcova, L.
    Kurnikova, E.
    Tereschenko, G.
    Nechesnyuk, A.
    Akhaladze, D.
    Fomin, D.
    Konovalov, D.
    Grachev, N.
    Likar, Y.
    Maschan, M.
    Varfolomeeva, S.
    Novichkova, G.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S170 - S170